Skip to main content

AVIVA PLC

Position in RPRX — Royalty Pharma plc

CIK 1140022 LONDON, X0

Position in RPRX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$20,136,138
+$4,602,349 QoQ
Shares Held
359,125
+10.9% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#107
of 645 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AVIVA PLC holds $284,688,734 across 21 Biotechnology names. RPRX ranks #5 (7.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 RPRX
Royalty Pharma plc
This page
359,125 $20,136,138

All Filings in RPRX

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,136,138 359,125
2026-03-31 $15,533,789 323,823
2025-12-31 $12,174,459 315,074
2025-09-30 $10,525,188 298,333
2025-06-30 $10,109,261 280,579
2025-03-31 $8,193,478 263,202
2024-12-31 $5,843,550 229,069
2024-09-30 $399,539 14,123
2024-06-30 $373,689 14,171
2024-03-31 $430,373 14,171
2023-12-31 $393,091 13,994
2023-09-30 $379,797 13,994
2023-06-30 $431,804 14,047
2023-03-31 $685,650 19,030
2022-12-31 $1,974,774 49,969
2022-09-30 $2,049,863 51,017
2022-06-30 $3,158,297 75,126
2022-03-31 $3,247,277 83,349
2021-12-31 $2,010,631 50,455
2021-09-30 $2,002,408 55,407
2021-06-30 $4,258,000 103,879
2021-03-31 $4,463,154 102,319
2020-12-31 $1,694,192 33,850